Aurora Cannabis (ACB) Income from Continuing Operations (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Income from Continuing Operations of 37532370.77 for Q1 2026, down 633.76% year-on-year from 7031747.36 in Q1 2025, and down 2953.2% on a QoQ basis from 1229279.24 in Q4 2025.
Aurora Cannabis (ACB) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Income from Continuing Operations for 10 consecutive years, with 37532370.77 the latest figure, recorded in Q1 2026.
- Quarterly Income from Continuing Operations fell 633.76% year-over-year to 37532370.77 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 86616359.18 (down 513.51% YoY) and the FY2026 annual result came in at 88454762.97, down 554.58% from the prior year.
- Income from Continuing Operations eased to 37532370.77 in Q1 2026 per ACB's latest filing, from 1229279.24 in the prior quarter.
- Over the last five years, Income from Continuing Operations for ACB reached as high as 32596636.09 in Q1 2024 and fell as low as 4711000000.0 in Q2 2023.
- A 5-year average of 446329301.13 and a median of 23927354.59 in 2025 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 5307.3% — and 2024, when it surged 261.68%.
- Year by year, Income from Continuing Operations stood at 538181388.66 in 2022, then jumped by 97.68% to 12511920.9 in 2023, then surged by 261.68% to 20229644.21 in 2024, then sank by 106.08% to 1229279.24 in 2025, then slumped by 2953.2% to 37532370.77 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 37532370.77, 1229279.24, and 33789254.27 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | -37.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.53 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Sep 30, 2025 | -33.79 Mn |
| Jun 30, 2025 | -14.07 Mn |
| Mar 31, 2025 | -5.12 Mn |
| Dec 31, 2024 | 20.23 Mn |
| Sep 30, 2024 | 977,893.25 |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 32.60 Mn |
| Dec 31, 2023 | -12.51 Mn |
| Sep 30, 2023 | -53.58 Mn |
| Jun 30, 2023 | -4.71 Bn |
| Dec 31, 2022 | -538.18 Mn |
| Sep 30, 2022 | -511.99 Mn |
| Jun 30, 2022 | -485.36 Mn |
| Mar 31, 2022 | -795.58 Mn |
| Dec 31, 2021 | -59.84 Mn |
| Sep 30, 2021 | -9.47 Mn |
| Jun 30, 2021 | -96.69 Mn |
| Mar 31, 2021 | -130.68 Mn |